Aldose reductase gene is associated with diabetic macroangiopathy in Japanese Type 2 diabetic patients

A Watarai1, E Nakashima, Y Hamada

  • 1Department of Endocrinology and Diabetes, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Abstract

Insights

Genetic variations in the aldose reductase (AR) gene, specifically the CT or TT genotype, are linked to an increased risk of stroke in Type 2 diabetic patients. This finding may aid in developing future stroke prevention strategies.

Area of Science:

  • Genetics
  • Metabolic Disorders
  • Cardiovascular Disease

Background:

  • The aldose reductase (AR) gene is crucial in the polyol pathway and has been linked to diabetic microangiopathy.
  • The association between AR gene variations and diabetic macroangiopathy, particularly stroke, remains under-investigated.
  • Understanding genetic predispositions can inform personalized medicine approaches for diabetes complications.

Purpose of the Study:

  • To investigate the association between genetic variations in the aldose reductase (AR) gene and susceptibility to diabetic macroangiopathy.
  • Specifically, to determine if AR gene polymorphisms influence the risk of stroke in Type 2 diabetic patients.
  • To explore the relationship between AR genotype and AR protein levels in erythrocytes.

Main Methods:

  • Genotyping of a single nucleotide polymorphism (C-106T) in the promoter region of the AR gene in 378 Type 2 diabetic patients.
  • Measurement of erythrocyte aldose reductase (AR) protein content using ELISA.
  • Statistical analysis, including logistic regression, to assess the association between AR genotype and stroke risk, adjusted for clinical factors.

Main Results:

  • No significant association was found between AR gene polymorphisms and ischaemic heart disease.
  • A significant increase in the frequency of the CT + TT genotype and T allele of the AR gene was observed in patients with stroke.
  • Erythrocyte AR protein content was elevated in individuals with the CT and TT genotypes compared to the CC genotype, with the association between AR genotype and stroke remaining significant after multivariate adjustment.

Conclusions:

  • The CT or TT genotype of the aldose reductase (AR) gene may serve as a genetic marker for stroke susceptibility in Type 2 diabetic individuals.
  • These findings could contribute to the development of targeted strategies for stroke prevention in diabetic populations.
  • Further research is warranted to elucidate the precise mechanisms linking AR gene variations to stroke risk.

Related Concept Videos

Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Exon Recombination02:32

Exon Recombination

The evolution of new genes is critical for speciation. Exon recombination, also known as exon shuffling or domain shuffling, is an important means of new gene formation. It is observed across vertebrates, invertebrates, and in some plants such as potatoes and sunflowers. During exon recombination, exons from the same or different genes recombine and produce new exon-intron combinations, which might evolve into new genes. 
Exon shuffling follows “splice frame rules.” Each exon has three reading...